ASEAN Poultry Vaccines Industry

The ASEAN poultry vaccines market size is expected to reach USD 253.22 million by 2030, registering a CAGR of 8.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include the increasing prevalence of poultry diseases, growing population, rapid urbanization, rising government initiatives, and reducing antibiotic usage.

For instance, The U.S. Bureau of Census data suggests that the ASEAN region’s (inclusive of 10 countries) total population grew by 11.6% in 2017 from 2008 and is expected to reach 720.0 million by 2027. In addition, according to Bloomberg, the urban population in the ASEAN region will grow by 100.0 million people by 2030. The region’s per capita GDP has grown annually by 3.4% in the last decade and is expected to grow by 3.5% in the next decade.

Furthermore, owing to the increasing poultry production in developing economies, concerns regarding food safety are growing. To prevent the spread of deadly diseases such as avian influenza in poultry farms, the governments of ASEAN countries are individually taking several measures. For instance, based on the Ministry of Agriculture Decree No. 4026, pathogenic Avian Influenza (AI) has been considered a notifiable disease in Indonesia, and the government has implemented actions to maintain AI control via vaccination, improved biosecurity measures, education & awareness, and routine surveillance. As part of its strategy, the country implemented intense vaccination among layer and breeder types.

Recently, Vietnam reported its first human H5 bird flu case as a result of infected chicken consumption in October 2022, which alerted the country to take strict measures with avian influenza vaccination drives. Similarly, governments of other ASEAN countries are taking a wide range of measures to control such severe infectious diseases to prevent economic loss. For instance, the Vietnamese government has collaborated with international organizations such as World Organization for Animal Health (WOAH), Food and Agriculture Organization (FAO) of the UN, and United States Agency for International Development (USAID) to implement the national animal disease control program 2019-2025. These measures improve the country’s poultry disease management and help develop safe meat supply chains.

Asian countries such as Malaysia, India, Nepal, South Korea, Vietnam, and the Philippines have reported Newcastle disease outbreaks in chickens. Due to these sudden outbreaks, governments are taking severe actions to implement vaccination drives and biosecurity measures. Moreover, according to an article published in the International Journal of Poultry Science, a study was conducted to determine how Malaysian government policies have affected broiler output in Peninsular Malaysia. Three different production sizes of chickens were produced and sold by contract and noncontract farmers in the study.

Gather more insights about the market drivers, restrains and growth of the Global ASEAN Poultry Vaccines market

ASEAN Poultry Vaccines Market Segments Highlights:

• The attenuated live vaccines segment led the market with the largest revenue share of 36.00% in 2024. The most traditional immunization technique in use in the veterinary industry is live attenuation.
• Based on disease, the avian influenza segment led the market with the largest revenue share of 9.93% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
• Based on application, the breeder segment led the market with the largest revenue share of 44.80% in 2024.
• Based on distribution channel, the hospital/clinic pharmacy segment led the market with the largest revenue share of 47.01% in 2024.
• The poultry vaccines market in Indonesia led the market with the largest market share of 18.99% in 2024, owing to the increasing chicken meat consumption and poultry production rates in the country, which further boosts the demand for import of technology for keeping, feeding, & storage.

ASEAN Poultry Vaccines Market Report Segmentation

Grand View Research has segmented the ASEAN poultry vaccines market on the basis of application, product, disease, distribution channel, and country:

ASEAN Poultry Vaccines Product Outlook (Revenue, USD Million, 2018 - 2030)

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

ASEAN Poultry Vaccines Application Outlook (Revenue, USD Million, 2018 - 2030)

• Broiler
• Layer
• Breeder

ASEAN Poultry Vaccines Disease Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Bronchitis
• Infectious Bursal Diseases
• Infectious Laryngotracheitis
• Egg Drop Syndrome
• Adenovirus
• Duck Viral Enteritis
• Inclusion Body Hepatitis
• Coccidiosis
• Avian Influenza
• Marek's Disease
• Newcastle Disease
• Salmonella
• Avian Encephalomyelitis
• Fowl Cholera
• Others

ASEAN Poultry Vaccines Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy

ASEAN Poultry Vaccines Country Outlook (Revenue, USD Million, 2018 - 2030)

• Thailand
• Vietnam
• Cambodia
• Indonesia
• Laos
• Malaysia
• Philippines
• Myanmar

Key ASEAN Poultry Vaccines Company Insights

• Boehringer Ingelheim International GmbH
• Ceva
• HIPRA
• Zoetis
• Phibro Animal Health Corporation
• Elanco
• Merck & Co., Inc.
• Medion Farma
• Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
• Kemin Industries, Inc

Order a free sample PDF of the ASEAN Poultry Vaccines Market Intelligence Study, published by Grand View Research.